Advanced Filters
noise

Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 3,189 clinical trials
L Luca Richeldi, MD

Patients With Interstitial Lung Disease

Prospective monocentric collection of data from adult patients with interstitial lung disease (ILD), to provide real-world data on current patient management at the ILD clinic.

18 years of age All Phase N/A
S Suzanne Judd, PhD

Risk Underlying Rural Areas Longitudinal Cohort Study (RURAL) Heart and Lung Study

The University of Texas Health Science Center at San Antonio (UTHSCSA) will serve as the site for the RURAL Study Coordinating Center, led by PI Vasan Ramachandran, MD. The primary function of the Study Coordinating Center (SCC) is to serve as an administrative liaison between all of the RURAL study's …

25 - 64 years of age All Phase N/A
K Kimberly Donnelly, Ph.D.

Interstitial Lung Disease Research Unit Biobank

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

18 years of age All Phase N/A

Registry of Autoimmune Interstitial Lung Disease

Interstitial lung diseases (ILD) constitute a group of entities characterized by inflammation and/or fibrosis of the lung parenchyma. In recent years, with the advent of new diagnostic tools and therapeutic options, multidisciplinary evaluation is essential, since it optimizes the interpretation of each case and the quality of care for these …

18 years of age All Phase N/A
J Jianhang He, MD

Early Intervention Strategies for Lung Cancer

Low-dose CT (LDCT)can detect and treat lung cancer earlier and more quickly, while expanded screening coverage helps reduce the incidence and mortality of respiratory diseases such as lung cancer. This study aims to conduct a single-arm cluster randomized trial of digitally enabled LDCT in Guangzhou to assess its intervention effectiveness …

40 - 74 years of age All Phase N/A
M Michael C. Stachowitz

Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.

18 years of age All Phase N/A
z zhi guo, Doctor

A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis

The goal of this observational study is to learn about risk of progressive pulmonary fibrosis (PPF). The main questions it aims to answer are: Risk factors of PPF Prevalence of PPF Mortality of PPF Patients with interstitial lung disease (ILD) of known or unknown etiology other than IPF who has …

18 - 80 years of age All Phase N/A
X Xue-qing Yu, Ph.D.

REspiratory diSEAse cohoRt Studies of CHinese Medicine for ILD (RESEARCH-ILD)

This study is a traditional Chinese medicine cohort for interstitial lung disease(ILD) in China, including at least 5000 patients with ILD and followed up for at least 5 years. The aim is to focus on the demographic characteristics, clinical features, disease occurrence and development characteristics, TCM syndrome evolution patterns, and …

18 years of age All Phase N/A
H Huaping Dai, M.D. Ph.D.

Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China

This project aimed to: 1) construct a cohort of no less than 10000 cases of f-ILD (including pneumoconiosis ≥3000 cases) with continuous regular follow-up to reveal the clinical phenotypes closely related to the development, progression and prognosis of pulmonary fibrosis; 2) systematically evaluate the safety and effectiveness of frozen lung …

years of age All Phase N/A
H Hannah Carlson

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.

18 years of age All Phase 3

Simplify language using AI